Trodelvy
Trodelvy ingredients
| Active ingredient | Strength |
|---|---|
| Sacituzumab Govitecan | 180 mg/1 |
What Trodelvy is used for
The FDA lists the approved uses on the official label (below). In the EU, sacituzumab govitecan is approved as Trodelvy for:
Triple-Negative Breast Cancer Trodelvy is indicated: as monotherapy for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy for metastatic disease and who are not candidates for PD-1 or PD-L1 inhibitor therapy (see section 5.1). as monotherapy for the treatment of adult patients with unresectable or metastatic TNBC who have received two or more prior systemic therapies, including at least one of them for advanced disease (see section 5.1) HR-Positive, HER2-Negative Breast Cancer Trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer who have received endocrine-based therapy, and at least two additional systemic therapies in the advanced setting.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Trodelvy
- Generic name
- Sacituzumab govitecan
- Made by
- Gilead Sciences, Inc.
- Forms
- Powder, For Solution
- Given
- Intravenous
- FDA approval
- Biologic licence (BLA) BLA761115
- On the US market since
- 2020
Official information
- Trodelvy prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Sacituzumab govitecan)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Trodelvy?
Trodelvy (Sacituzumab govitecan) is a cancer medicine made by Gilead Sciences, Inc., approved by the US FDA.
What are the ingredients of Trodelvy?
Trodelvy contains Sacituzumab Govitecan (180 mg/1).
Is Trodelvy approved in Europe?
The same active substance is approved in the EU as Trodelvy.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA